Biktarvy, formally known as bictegravir sulfate, represents a potent single-tablet therapy for controlling HIV infection. This medication integrates three key antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It works by preventing the virus's ability to replicate within the body, significantly decreasing the viral quantity.